If no evidence of retinopathy is found and glycemic control is stable, examinations every 1-2 years may be considered
Modern double-blind RCT, older human study, or mechanistic extrapolation
Therefore, the use of exogenous biologics, combined with advanced clinical methodologies and surgical techniques, represents a promising solution to safely promoting graft transplant success [2]
Studies with PYY agonists administered intravenously have shown reduction in food intake with increased satiety [92, 93], however, a nasal PYY agonist showed minimal efficacy with poor tolerability [94]
A study of 5,067 overweight and obese T2D patients failed to demonstrate an association between mild weight reduction and improved cardiac function